Cochrane Abstracts
Phosphodiesterase type 5 inhibitor plus endothelin receptor antagonist compared to either alone for group 1 pulmonary arterial hypertension
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Phosphodiesterase Type 5 Inhibitor Plus Endothelin Receptor Antagonist Compared to Either Alone for Group 1 Pulmonary Arterial Hypertension." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440782/all/Phosphodiesterase_type_5_inhibitor_plus_endothelin_receptor_antagonist_compared_to_either_alone_for_group_1_pulmonary_arterial_hypertension.
Phosphodiesterase type 5 inhibitor plus endothelin receptor antagonist compared to either alone for group 1 pulmonary arterial hypertension. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440782/all/Phosphodiesterase_type_5_inhibitor_plus_endothelin_receptor_antagonist_compared_to_either_alone_for_group_1_pulmonary_arterial_hypertension. Accessed January 23, 2026.
Phosphodiesterase type 5 inhibitor plus endothelin receptor antagonist compared to either alone for group 1 pulmonary arterial hypertension. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440782/all/Phosphodiesterase_type_5_inhibitor_plus_endothelin_receptor_antagonist_compared_to_either_alone_for_group_1_pulmonary_arterial_hypertension
Phosphodiesterase Type 5 Inhibitor Plus Endothelin Receptor Antagonist Compared to Either Alone for Group 1 Pulmonary Arterial Hypertension [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440782/all/Phosphodiesterase_type_5_inhibitor_plus_endothelin_receptor_antagonist_compared_to_either_alone_for_group_1_pulmonary_arterial_hypertension.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Phosphodiesterase type 5 inhibitor plus endothelin receptor antagonist compared to either alone for group 1 pulmonary arterial hypertension
ID - 440782
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440782/all/Phosphodiesterase_type_5_inhibitor_plus_endothelin_receptor_antagonist_compared_to_either_alone_for_group_1_pulmonary_arterial_hypertension
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
